In our previous investigations, we have successfully isolated and characterized CD44+ cells in which the expression of embryonic/cancer stem cell markers OCT4, SOX2, and NANOG was significantly higher than in the CD44− cell populations [24]. The gene discussed is SOX2; the disease is cancer.